They determined whether therapeutic effects of antidepressant drug treatment affects binding of [11C]harmine by monoamine oxidase type A, and whether recurrence of depression is associated with the level of [11C]harmine binding in brain regions. The gene discussed is MAOA; the disease is depressive symptom measurement.